$TGAAU

2023 Q4 Form 10-K Financial Statement

#000119312524086733 Filed on April 04, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $799.7K $2.161M
YoY Change 2418.74% 96.92%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $799.7K $2.161M
YoY Change 2418.74% 96.92%
Operating Profit -$2.161M
YoY Change 96.92%
Interest Expense $603.0K $5.720M
YoY Change -67.46% 88.73%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0%
Pretax Income -$196.7K $3.559M
YoY Change -110.8% 81.25%
Income Tax
% Of Pretax Income
Net Earnings -$196.7K $3.559M
YoY Change -110.8% 81.25%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.02 $0.21
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.630K $4.630K
YoY Change -98.83% -98.83%
Cash & Equivalents $4.625K
Short-Term Investments
Other Short-Term Assets $25.75K $25.75K
YoY Change -76.96% -76.96%
Inventory
Prepaid Expenses $25.75K
Receivables
Other Receivables
Total Short-Term Assets $30.38K $30.38K
YoY Change -94.0% -94.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $43.42M $43.42M
YoY Change -80.46% -80.46%
Other Assets
YoY Change
Total Long-Term Assets $43.42M $43.42M
YoY Change -80.46% -80.46%
TOTAL ASSETS
Total Short-Term Assets $30.38K $30.38K
Total Long-Term Assets $43.42M $43.42M
Total Assets $43.45M $43.45M
YoY Change -80.49% -80.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $825.7K $825.7K
YoY Change 423.21% 423.21%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.011M $2.011M
YoY Change 302.2% 302.2%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.101M $3.101M
YoY Change 294.87% 294.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $3.761M $3.761M
YoY Change -50.0% -50.0%
Total Long-Term Liabilities $3.761M $3.761M
YoY Change -50.0% -50.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.101M $3.101M
Total Long-Term Liabilities $3.761M $3.761M
Total Liabilities $6.861M $6.861M
YoY Change -17.4% -17.4%
SHAREHOLDERS EQUITY
Retained Earnings -$6.832M
YoY Change -12.43%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.59M $36.59M
YoY Change
Total Liabilities & Shareholders Equity $43.45M $43.45M
YoY Change -80.49% -80.49%

Cashflow Statement

Concept 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$196.7K $3.559M
YoY Change -110.8% 81.25%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$495.7K -$1.271M
YoY Change 19.7% 18.79%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $5.912M $184.5M
YoY Change
Cash From Investing Activities $5.912M $184.5M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$6.182M -$185.2M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.481M -183.7M
YoY Change -1196.27% -40212.75%
NET CHANGE
Cash From Operating Activities -495.7K -1.271M
Cash From Investing Activities 5.912M 184.5M
Cash From Financing Activities -5.481M -183.7M
Net Change In Cash -64.72K -389.6K
YoY Change -175.36% -36.32%
FREE CASH FLOW
Cash From Operating Activities -$495.7K -$1.271M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001847355
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Grand Cayman
CY2023 dei Entity Address Country
EntityAddressCountry
KY
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41135
CY2023 dei Entity Registrant Name
EntityRegistrantName
TARGET GLOBAL ACQUISITION I CORP.
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
PO BOX 10176
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
GOVERNOR’S SQUARE
CY2023 dei Entity Address Address Line3
EntityAddressAddressLine3
23 LIME TREE BAY AVENUE
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-1002
CY2023 dei City Area Code
CityAreaCode
345
CY2023 dei Local Phone Number
LocalPhoneNumber
814 5772
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
42174838
CY2023 dei Auditor Firm
AuditorFirmId
688
CY2023 dei Auditor Name
AuditorName
Marcum LLP
CY2023 dei Auditor Location
AuditorLocation
Houston, Texas
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Cash
Cash
4625
CY2022Q4 us-gaap Cash
Cash
394251
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25750
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
111739
CY2023Q4 us-gaap Assets Current
AssetsCurrent
30375
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3100649
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
785224
CY2022Q4 us-gaap Assets Current
AssetsCurrent
505990
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
43419605
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
222234685
CY2023Q4 us-gaap Assets
Assets
43449980
CY2022Q4 us-gaap Assets
Assets
222740675
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
825683
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
157805
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
263951
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
127419
CY2023Q4 tgaau Promissory Note Related Party Current
PromissoryNoteRelatedPartyCurrent
2011015
CY2022Q4 tgaau Promissory Note Related Party Current
PromissoryNoteRelatedPartyCurrent
500000
CY2023Q4 tgaau Deferred Underwriting Commissions
DeferredUnderwritingCommissions
3760690
CY2022Q4 tgaau Deferred Underwriting Commissions
DeferredUnderwritingCommissions
7521380
CY2023Q4 us-gaap Liabilities
Liabilities
6861339
CY2022Q4 us-gaap Liabilities
Liabilities
8306604
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
43419605
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
222234685
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6831501
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7801151
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6830964
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-7800614
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
43449980
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
222740675
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2161025
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1097439
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-2161025
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1097439
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
5719743
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3030633
CY2023 tgaau Change In Fair Value Of Over Allotment Liability
ChangeInFairValueOfOverAllotmentLiability
0
CY2022 tgaau Change In Fair Value Of Over Allotment Liability
ChangeInFairValueOfOverAllotmentLiability
30207
CY2023 us-gaap Other Income
OtherIncome
5719743
CY2022 us-gaap Other Income
OtherIncome
3060840
CY2023 us-gaap Net Income Loss
NetIncomeLoss
3558718
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1963401
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-6723842
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3040173
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1963401
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-7800614
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
6349758
CY2023 tgaau Adjustments To Additional Paid In Capital Waiver Of Deferred Underwriters Discount
AdjustmentsToAdditionalPaidInCapitalWaiverOfDeferredUnderwritersDiscount
3760690
CY2023 us-gaap Net Income Loss
NetIncomeLoss
3558718
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6830964
CY2023 us-gaap Net Income Loss
NetIncomeLoss
3558718
CY2022 us-gaap Net Income Loss
NetIncomeLoss
1963401
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
5719743
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3030633
CY2023 tgaau Change In Fair Value Of Over Allotment Liability
ChangeInFairValueOfOverAllotmentLiability
0
CY2022 tgaau Change In Fair Value Of Over Allotment Liability
ChangeInFairValueOfOverAllotmentLiability
30207
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-85989
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-252712
CY2023 tgaau Accounts Payable And Accrued Expenses
AccountsPayableAndAccruedExpenses
667878
CY2022 tgaau Accounts Payable And Accrued Expenses
AccountsPayableAndAccruedExpenses
-344940
CY2023 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
136532
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
120000
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1270626
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1069667
CY2023 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
630015
CY2022 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0
CY2023 tgaau Cash Withdrawn From Trust Account For Stock Redemptions
CashWithdrawnFromTrustAccountForStockRedemptions
185164838
CY2022 tgaau Cash Withdrawn From Trust Account For Stock Redemptions
CashWithdrawnFromTrustAccountForStockRedemptions
0
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
184534823
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1511015
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
457844
CY2023 tgaau Payment From Cash Withdrawn From Trust Account For Stock Redemptions
PaymentFromCashWithdrawnFromTrustAccountForStockRedemptions
185164838
CY2022 tgaau Payment From Cash Withdrawn From Trust Account For Stock Redemptions
PaymentFromCashWithdrawnFromTrustAccountForStockRedemptions
0
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-183653823
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
457844
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-389626
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-611823
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
394251
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1006074
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4625
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
394251
CY2023 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
6349758
CY2022 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3040173
CY2023 tgaau Impact Of The Waiver Of Deferred Underwriters Discount
ImpactOfTheWaiverOfDeferredUnderwritersDiscount
3760690
CY2022 tgaau Impact Of The Waiver Of Deferred Underwriters Discount
ImpactOfTheWaiverOfDeferredUnderwritersDiscount
0
CY2023 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-02-02
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14896580
CY2023Q4 tgaau Percentage Of Amount Of Trust Assets Of Target Company Excluding Underwriting Commission Working Capital And Taxes
PercentageOfAmountOfTrustAssetsOfTargetCompanyExcludingUnderwritingCommissionWorkingCapitalAndTaxes
0.80
CY2021Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.2
CY2023Q4 tgaau Interest Income On Trust Account To Be Set Aside To Pay Dissolution Expenses
InterestIncomeOnTrustAccountToBeSetAsideToPayDissolutionExpenses
100000
CY2023 tgaau Extended Period On Or Before Which Business Combination Shall Be Consummated
ExtendedPeriodOnOrBeforeWhichBusinessCombinationShallBeConsummated
P24M
CY2023Q4 tgaau Cash Outside The Trust Account
CashOutsideTheTrustAccount
4625
CY2023Q4 tgaau Working Capital Deficit
WorkingCapitalDeficit
3070274
CY2023 us-gaap Proceeds From Unsecured Notes Payable
ProceedsFromUnsecuredNotesPayable
950000
CY2023 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
630015
CY2022 tgaau Redeemable Percentage Of Outstanding Public Shares
RedeemablePercentageOfOutstandingPublicShares
1
CY2023Q4 tgaau Interest Income On Trust Account To Be Set Aside To Pay Dissolution Expenses
InterestIncomeOnTrustAccountToBeSetAsideToPayDissolutionExpenses
100000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. </div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div>
CY2023Q4 us-gaap Cash
Cash
4625
CY2022Q4 us-gaap Cash
Cash
394251
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
43419605
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
222234685
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div> <div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance coverage limit of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3040173
CY2023 tgaau Redemption Of Shares
RedemptionOfShares
-185164838
CY2023 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
6349758
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2021Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
219194512
tgaau Percentage Of Shares Issuable Upon Conversion
PercentageOfSharesIssuableUponConversion
50
CY2021Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
500000
CY2023 tgaau Offering Proceeds Allocated To Offering Expenses
OfferingProceedsAllocatedToOfferingExpenses
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023 tgaau Number Of Days After Consummation Of Business Combination Within Which The Securities Shall Be Registered
NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichTheSecuritiesShallBeRegistered
P20D
CY2023 tgaau Number Of Days After Which Business Combination Within Which Securities Registration Shall Be Effective
NumberOfDaysAfterWhichBusinessCombinationWithinWhichSecuritiesRegistrationShallBeEffective
P60D
CY2023Q4 tgaau Class Of Warrants And Rights Issued During The Period
ClassOfWarrantsAndRightsIssuedDuringThePeriod
14191092
CY2023Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
43419605
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
222234685

Files In Submission

Name View Source Status
0001193125-24-086733-index-headers.html Edgar Link pending
0001193125-24-086733-index.html Edgar Link pending
0001193125-24-086733.txt Edgar Link pending
0001193125-24-086733-xbrl.zip Edgar Link pending
d778542d10k.htm Edgar Link pending
d778542dex191.htm Edgar Link pending
d778542dex311.htm Edgar Link pending
d778542dex312.htm Edgar Link pending
d778542dex321.htm Edgar Link pending
d778542dex322.htm Edgar Link pending
d778542dex41.htm Edgar Link pending
d778542dex971.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
d778542d10k_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tgaau-20231231.xsd Edgar Link pending
tgaau-20231231_def.xml Edgar Link unprocessable
tgaau-20231231_lab.xml Edgar Link unprocessable
tgaau-20231231_pre.xml Edgar Link unprocessable
tgaau-20231231_cal.xml Edgar Link unprocessable